EHC - NYSE

Encompass Health Corporation

EHC·NYSE

$103.17

+1.4%

HealthcareMedical - Care Facilities

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$10.23B

EPS5.6200

P/E Ratio18.36

Earnings Date08/03/2026

7.09B

Assets

3Y+26.0%

5Y+10.0%

10Y+51.0%

3.81B

Total Liabilities

3Y+1.0%

5Y-14.0%

10Y+6.0%

3.28B

Total Equity

15%

3Y+76.0%

5Y+64.0%

10Y+207.0%

Encompass Health Corporation Funding & Solvency Profile

EHC · NYSE

Current Assets

Cash & Cash Equivalents102.90M

Net Receivables619.20M

Inventory0.00

Other Current Assets87.70M

Total Current Assets906 M

Non-Current Assets

Property, Plant & Equipment4.31B

Goodwill & Intangible Assets1.63B

Long-Term Investments129.10M

Other Non-Current Assets114.60M

Total Non-Current Assets5 B

Total Assets

7.09B

Financial Health Analysis

Current Ratio

1.08x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.16x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

70 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

13% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Encompass Health Corporation Balance Sheet

EHC • NYSE

Encompass Health Corporation Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	102.9M	85.4M	104.2M	21.8M	49.4M	224M	94.8M	69.2M	54.4M	40.5M	61.6M	66.7M	64.5M	132.8M	30.1M	48.4M	80.9M	32.2M	19.8M	40.6M
Short-Term Investments	42.2M	0.0	37.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15M	18.2M	2.7M	20.3M	28.9M	37.5M
Cash & Short-Term Investments	145.1M	85.4M	141.8M	21.8M	49.4M	224M	94.8M	69.2M	54.4M	40.5M	61.6M	66.7M	64.5M	132.8M	45.1M	66.6M	83.6M	52.5M	48.7M	78.1M
Net Receivables	619.2M	598.8M	611.6M	536.8M	502.1M	563M	498.7M	467.7M	472.1M	443.8M	410.5M	323.2M	261.8M	249.3M	222.8M	224.9M	219.7M	417.7M	447.7M	608M
Accounts Receivables	619.2M	598.8M	611.6M	536.8M	502.1M	563M	498.7M	467.7M	472.1M	443.8M	410.5M	323.2M	261.8M	249.3M	222.8M	224.9M	219.7M	234.9M	217.7M	217.3M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	182.8M	230M	230M
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59M	62.4M	60.9M	45.9M	234M	191.4M	186.8M	0.0	0.0	0.0	178.2M	88.5M	138.7M
Prepaids	53.9M	42.3M	34.5M	34.9M	114.9M	86.4M	97.5M	66.2M	113.3M	109.3M	80.7M	62.7M	62.7M	67.9M	76.2M	50.1M	54.4M	24.2M	24.9M	38.2M
Other Current Assets	87.7M	160.4M	53.9M	123.7M	255M	75.2M	64.8M	59M	62.4M	60.9M	45.9M	234M	191.4M	186.8M	71.5M	64.6M	68.3M	34.4M	116.1M	56.4M
Total Current Assets	905.9M	886.9M	841.8M	717.2M	921.4M	948.6M	755.8M	662.1M	702.2M	654.5M	598.7M	686.6M	580.4M	636.8M	391M	406.2M	426M	682.7M	637.4M	880.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	4.3B	3.8B	3.5B	3.2B	2.8B	2.5B	2.2B	1.6B	1.5B	1.4B	1.3B	1B	910.5M	748M	664.4M	685.4M	664.8M	674.3M	744.4M	1.1B
Goodwill	1.3B	1.3B	1.3B	1.3B	1.2B	2.3B	2.3B	2.1B	2B	1.9B	1.9B	1.1B	456.9M	437.3M	421.7M	431.3M	416.4M	414.7M	406.1M	896.9M
Intangible Assets	308.3M	297.8M	278.2M	282.3M	158.4M	431.3M	476.3M	443.4M	403.1M	411.3M	419.4M	306.1M	88.2M	73.2M	57.7M	48.8M	37.4M	42.8M	26.1M	54.1M
Goodwill & Intangible Assets	1.6B	1.6B	1.6B	1.5B	1.4B	2.8B	2.8B	2.5B	2.4B	2.3B	2.3B	1.4B	545.1M	510.5M	479.4M	480.1M	453.8M	457.5M	432.2M	951M
Long-Term Investments	129.1M	122.5M	109.5M	0.0	0.0	5.5M	7.4M	74.2M	56.1M	46.5M	51.8M	9.4M	20.3M	20.8M	29M	30.7M	29.3M	37M	43M	38M
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.3M	63.6M	75.8M	190.8M	129.4M	354.3M	393.1M	608.1M	679.3M	10M	-37M	-43M	-38M
Other Non-Current Assets	114.6M	96.7M	82.1M	222.1M	1.8B	289.5M	300.2M	216.8M	179M	174.8M	145.2M	173.6M	123.8M	114.6M	99.3M	90.4M	97.6M	183.7M	236.6M	432.3M
Total Non-Current Assets	6.2B	5.6B	5.3B	4.9B	5.9B	5.5B	5.3B	4.6B	4.2B	4B	4B	2.7B	2B	1.8B	1.9B	2B	1.3B	1.3B	1.4B	2.5B
Total Assets	7.1B	6.5B	6.1B	5.6B	6.9B	6.4B	6.1B	5.2B	4.9B	4.7B	4.6B	3.4B	2.5B	2.4B	2.3B	2.4B	1.7B	2B	2.1B	3.4B
LIABILITIES
CURRENT LIABILITIES
Total Payables	178.2M	171M	170M	132.9M	134M	115M	94.6M	90M	78.4M	68.3M	61.6M	53.4M	61.9M	45.3M	45.4M	48.9M	50.2M	45.5M	48.7M	105.1M
Accounts Payable	178.2M	171M	170M	132.9M	134M	115M	94.6M	90M	78.4M	68.3M	61.6M	53.4M	61.9M	45.3M	45.4M	48.9M	50.2M	45.5M	48.7M	67.5M
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.2M
Accrued Expenses	0.0	0.0	207.5M	211.1M	289.4M	344.9M	384M	254.1M	257.7M	234.1M	196.4M	180.1M	156.7M	85.7M	85M	80M	77.9M	89.8M	92.8M	117.2M
Short Term Debt	70.1M	114.9M	48.9M	25.2M	18.7M	14.5M	18.3M	35.8M	32.3M	37.1M	36.8M	20.8M	12.3M	13.6M	18.9M	14.5M	21.5M	24.8M	68.3M	37M
Capital Lease Obligations (Current)	0.0	50M	0.0	25.6M	42.6M	68.6M	61.4M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.8M	196.8M	173.1M	155.9M	144.5M	114.6M	111.6M	107.5M	101.5M	130.9M	97.9M	93.2M	167.1M
Other Current Liabilities	588.1M	505.1M	230M	181.1M	264.1M	174.3M	162.7M	292.6M	149.1M	136.1M	131.6M	110M	80.7M	156.3M	156.6M	215.9M	241.6M	586.1M	760.7M	1B
Total Current Liabilities	836.4M	841M	656.4M	575.9M	748.8M	717.3M	721M	672.5M	517.5M	475.6M	426.4M	364.3M	311.6M	300.9M	313.2M	359.3M	391.2M	746.2M	970.5M	1.3B
NON-CURRENT LIABILITIES
Long Term Debt	2.2B	2.1B	2.4B	2.7B	2.9B	2.9B	2.6B	2.5B	2.5B	3B	3.1B	2.1B	1.5B	1.2B	1.2B	1.5B	1.6B	1.8B	2B	3.4B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	387.4M	387.4M	387.4M
Deferred Tax Liabilities (Non-Current)	126.8M	105.2M	87M	83M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7M	29.8M	80M
Other Non-Current Liabilities	206.9M	190.4M	177.9M	174.2M	296.8M	266.8M	159.9M	205.2M	185.3M	160M	-131.7M	136.3M	53.3M	136.7M	520.6M	518.2M	546.9M	-370.8M	-241.6M	60.9M
Total Non-Current Liabilities	3B	2.8B	3.1B	3.2B	3.7B	3.7B	3.4B	2.7B	2.7B	3.1B	3.3B	2.2B	1.6B	1.4B	1.8B	2B	2.2B	2.3B	2.5B	4B
Capital Lease Obligations	464.7M	534.4M	514.6M	225.3M	611.4M	674.1M	696.3M	247.1M	255.5M	265.7M	276.3M	86.7M	88.9M	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	3.8B	3.7B	3.8B	3.8B	4.5B	4.4B	4.1B	3.4B	3.2B	3.6B	3.7B	2.6B	2B	1.7B	2.1B	2.4B	2.6B	3.1B	3.5B	5.3B
SHAREHOLDERS' EQUITY
Treasury Stock	-722.5M	-577.9M	-547.2M	-536.7M	-521.2M	-497.4M	-492.3M	-427.9M	-418.5M	-614.7M	-527.4M	-458.7M	-404.6M	-163.3M	-148.8M	-141.8M	-137.5M	-311.5M	-310.4M	-322.7M
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.2M	93.2M	342.2M	387.4M	0.0	387.4M	387.4M	387.4M	0.0
Common Stock	1.2M	1.2M	1.2M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	1.1M	611.4M	473.2M	344.6M	1M	1M	1M	1M	1M	900K	900K
Additional Paid-In Capital	1.9B	1.8B	1.8B	1.7B	2.3B	2.3B	2.4B	2.6B	2.7B	2.8B	2.8B	2.8B	2.8B	2.9B	2.9B	2.9B	2.9B	3B	2.8B	2.8B
Retained Earnings	1.3B	796.7M	406.5M	115.7M	141.8M	-242.3M	-526.5M	-885.2M	-1.2B	-1.4B	-1.7B	-1.9B	-2.1B	-2.4B	-2.6B	-2.8B	-3.7B	-3.8B	-4.1B	-4.7B
Accumulated Other Comprehensive Income/Loss	500K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-1.3M	-1.2M	-1.2M	-500K	-100K	1.4M	-200K	500K	-387.4M	-3.2M	-800K	1.5M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	-1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2M	0.0	0.0	387.4M	-774.8M	0.0	401.6M
Total Stockholders' Equity	2.4B	2.1B	1.6B	1.3B	1.9B	1.6B	1.4B	1.3B	1.2B	735.9M	611.4M	566.4M	437.8M	633.8M	117M	-85.2M	-974M	-1.2B	-1.6B	-2.2B
Total Equity	3.3B	2.8B	2.3B	1.9B	2.4B	2B	1.9B	1.9B	1.6B	1.1B	900.4M	797.4M	575.4M	746.3M	201.6M	-2.2M	-897.6M	-1.1B	-1.5B	-1.9B
Minority Interest	837.6M	782.2M	649.7M	551.6M	487.9M	413.6M	580.5M	542M	463.8M	331.1M	289M	231M	137.6M	112.5M	84.6M	83M	76.4M	82.2M	97.2M	271.1M
SUMMARY
Total Liabilities & Equity	7.1B	6.5B	6.1B	5.6B	6.9B	6.4B	6.1B	5.2B	4.9B	4.7B	4.6B	3.4B	2.5B	2.4B	2.3B	2.4B	1.7B	2B	2.1B	3.4B
Total Investments	171.3M	122.5M	147.1M	0.0	0.0	5.5M	7.4M	74.2M	56.1M	46.5M	51.8M	9.4M	20.3M	20.8M	44M	48.9M	32M	57.3M	71.9M	75.5M
Total Debt	2.7B	2.7B	2.9B	3B	3.5B	3.5B	3.3B	2.5B	2.6B	3B	3.2B	2.1B	1.5B	1.3B	1.3B	1.5B	1.7B	1.8B	2B	3.4B
Net Debt	2.6B	2.6B	2.8B	3B	3.4B	3.3B	3.3B	2.4B	2.5B	3B	3.1B	2.1B	1.5B	1.1B	1.2B	1.5B	1.6B	1.8B	2B	3.4B
Shares Outstanding	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834	100,619,834

SEC Filings

EHC - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 01, 2026	May 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 15, 2026	May 14, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 11, 2026	May 07, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 01, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 10, 2026	March 09, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 26, 2026	December 31, 2025	2025	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	February 20, 2026	February 19, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 05, 2026	February 05, 2026	2026	View Filing

Showing 1 to 10 of 759 filings

Related Guides

Blog Categories

Continue your EHC research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.